Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-20

Clinical Trial Update: Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the effect of green tea extract on soluble RAGE in patients with diabetic nephropathy. The current status of the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Diabetic Nephropathy Type 2 | Phase 2 | Status: UNKNOWN